Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. sensus

SensUS

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 SensUS project word cloud

Explore the words cloud of the SensUS project. It provides you a very rough idea of what is the project "SensUS" about.

mother    few    risk    reliability    solutions    company    operator    milestones    investment    alone    healthcare    secured    qualitative    recommends    turn    17    invasive    doctors    view    device    secure    involve    exceed    cs    shows    registering    decisions    monitor    timeline    patented    quality    worldwide    benefits    software    people    15    labour    events    rate    extra    gain    obstetrics    placing    details    baby    performed    prepare    400    errors    mothers    hire    return    strategy    commercial    validated    million    amolab    quantitative    50    finalise    sections    69    monitoring    informed    wellbeing    offers    sensus    29    point    suitable    childbirth    guide    unnecessary    see    expecting    subjective    babies    maturity    financial    market    ultrasound    today    assign    750    labours    technological    risks    once    validating    proprietary    skills    goals    reducing    contains   

Project "SensUS" data sheet

The following table provides information about the project.

Coordinator		 AMOLAB SRL 

Organization address
address: VIA RAFFAELLO SANZIO 18
city: LECCE
postcode: 73100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website https://www.amolab.it/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2018-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AMOLAB SRL IT (LECCE) coordinator 50˙000.00

Map

 Project objective

Today the obstetrics sector is registering an increase in the C-Sections (CS) performed worldwide. Over 50% of CS are unnecessary, placing mother & baby under unnecessary risk. Unnecessary CS cause an extra cost of €750 million per year to the healthcare system in Europe. Although the WHO recommends not to exceed a rate of 15% of CS, Europe alone shows a rate of 29%. Most of the extra CS performed are due to errors during the monitoring of labour events. The few ultrasound devices available to monitor the labour timeline provide qualitative subjective information, depend on the operator skills, and some involve invasive procedures. Thus, new solutions are needed to help doctors take better informed decisions. In response to this need, we at AMOLAB have developed, patented and validated SensUS, a unique ultrasound device for quantitative & objective monitoring of childbirth events. This device contains our proprietary software, which measures selected validated parameters of the labour process. SensUS offers doctors objective details to support and guide their decisions during childbirth monitoring. In turn, it will allow to assign CS only to those cases that need it, reducing risks, costs and enhancing healthcare quality. After validating the reliability of SensUS on over 400 labours, we now want to take SensUS to market maturity. This project aims to finalise its technological development and secure its commercial aspects. To accomplish these goals, in Phase 1 we aim to evaluate the main milestones of the project from a technical, commercial and financial point of view, and prepare the most suitable strategy to achieve them. Once the project is completed and SensUS reaches the market, our technology will bring significant benefits to the obstetrics sector, as well as for the wellbeing of mothers and babies. In turn, AMOLAB will see its growth secured as a company, expecting to hire new 17 people and gain a Return of Investment of €4.69 from this project in 5 years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SENSUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SENSUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More